ArticlePloS one2018

Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease.

Ahmed Al-Darraji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.